Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1254, 2000-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Chemotherapy for all younger women with breast cancer?
Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. :
Access to resources
Recommend
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
Endocrine therapy needed in younger, ER-positive women?
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
HRT `safe' for use in women with breast cancer?
Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. :
Dasatinib: a novel therapy for breast cancer?
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. :